Document Detail


Ocular adverse effects of alendronic acid.
MedLine Citation:
PMID:  11718170     Owner:  HSR     Status:  MEDLINE    
Abstract/OtherAbstract:
(1) The ocular adverse effects of pamidronic acid are rare but well documented. The main risk is anterior uveitis. (2) Similar disorders have been linked to alendronic acid and risedronic acid. The ocular manifestations occur rapidly after treatment introduction and resolve on treatment cessation. (3) The other diphosphonates seem to be exempt from this ocular risk.
Authors:
-
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Prescrire international     Volume:  10     ISSN:  1167-7422     ISO Abbreviation:  Prescrire Int     Publication Date:  2001 Jun 
Date Detail:
Created Date:  2001-11-21     Completed Date:  2002-01-25     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  9439295     Medline TA:  Prescrire Int     Country:  France    
Other Details:
Languages:  eng     Pagination:  82     Citation Subset:  T    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Alendronate / adverse effects*
Amines / adverse effects
Diphosphonates / adverse effects
Eye Diseases / chemically induced*
Humans
Chemical
Reg. No./Substance:
0/Amines; 0/Diphosphonates; 66376-36-1/Alendronate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Verteporfin: new preparation. In combination with laser therapy: helpful in some forms of age-relate...
Next Document:  Acupuncture: searching for benefits.